Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience.

Authors
Publication date
1 January 2015
Publisher
Impact Journals Ltd, 6211 Tipton House, Ste 6, Albany, Usa, Ny, 12203 (USA)

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Padua Research Archive

    redirect
    oaioai:www.research.unipd.it:1157...
    Last time updated on 30/11/2020